<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Technology Archives - Heart Valve Voice US</title>
	<atom:link href="https://www.heartvalvevoice-us.org/tag/technology/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.heartvalvevoice-us.org/tag/technology/</link>
	<description>Giving a voice to people with heart valve disease</description>
	<lastBuildDate>Mon, 18 Oct 2021 18:27:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.heartvalvevoice-us.org/wp-content/uploads/2019/02/cropped-Favicon-32x32.png</url>
	<title>Technology Archives - Heart Valve Voice US</title>
	<link>https://www.heartvalvevoice-us.org/tag/technology/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HVD Policy Task Force Comments on MCIT Repeal</title>
		<link>https://www.heartvalvevoice-us.org/medicare-coverage-of-innovative-technology-rule/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Mon, 18 Oct 2021 17:59:09 +0000</pubDate>
				<category><![CDATA[Comment Letter]]></category>
		<category><![CDATA[Policy Center]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://www.heartvalvevoice-us.org/?p=11018</guid>

					<description><![CDATA[<p>Dear Administrator Brooks-LaSure: Heart Valve Voice US is submitting these comments on behalf of the Heart Valve Disease PolicyTask Force, which we chair. One in eight people over age 75 suffers from moderate to severeheart valve disease, placing a serious health burden on older Americans. As advocatesfor thesepatients, we are dismayed and disappointed in the [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/medicare-coverage-of-innovative-technology-rule/">HVD Policy Task Force Comments on MCIT Repeal</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)</title>
		<link>https://www.heartvalvevoice-us.org/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and-necessary-delay-of-effective-date-docket-no-cms-2021-05490/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 20 Apr 2021 21:12:00 +0000</pubDate>
				<category><![CDATA[Policy Center]]></category>
		<category><![CDATA[Policy Statement]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://www.heartvalvevoice-us.org/?p=10886</guid>

					<description><![CDATA[<p>The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared interest of ensuring that patientshave access to safe, innovative new technologies – “Breakthrough Devices” – as soonas possible after receiving market authorization from the Food and Drug Administration. While we understand the rationale behind delaying [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and-necessary-delay-of-effective-date-docket-no-cms-2021-05490/">Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies</title>
		<link>https://www.heartvalvevoice-us.org/hvvus-expresses-thoughts-on-medicare-coverage-for-innovative-technologies/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Tue, 10 Nov 2020 15:56:52 +0000</pubDate>
				<category><![CDATA[Policy Center]]></category>
		<category><![CDATA[Policy Statement]]></category>
		<category><![CDATA[MCIT]]></category>
		<category><![CDATA[Patient Resource]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10718</guid>

					<description><![CDATA[<p>Heart Valve Voice US is a nonprofit patient advocacy organization that provides a united voicefor people living with heart valve disease. We advocate for early detection, meaningful support,and timely access to appropriate treatment for all people affected by heart valve disease. Theprimary goal of this proposed rule aligns with our mission and we look forward [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/hvvus-expresses-thoughts-on-medicare-coverage-for-innovative-technologies/">HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Bill Introduced to Combat Counterfeit Medical Devices</title>
		<link>https://www.heartvalvevoice-us.org/bill-introduced-to-combat-counterfeit-medical-devices/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Wed, 11 Mar 2020 19:53:29 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10376</guid>

					<description><![CDATA[<p>On Jan. 29, 2020, the House Energy &#38; Commerce Committee Subcommittee on Health held a hearing on multiple bills related to improving safety and transparency around food and medical products. Among the bills considered during the hearing was the Safeguarding Therapeutics Act (H.R. 5663). Introduced on Jan. 21, 2020 by Representatives Eliot Engel (D-N.Y.) and [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/bill-introduced-to-combat-counterfeit-medical-devices/">Bill Introduced to Combat Counterfeit Medical Devices</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Durbin Issues Bill to Safeguard Foreign-Manufactured Medical Technology</title>
		<link>https://www.heartvalvevoice-us.org/durbin-issues-bill-to-safeguard-foreign-manufactured-medical-technology/</link>
		
		<dc:creator><![CDATA[Erin Fedorchak]]></dc:creator>
		<pubDate>Wed, 11 Mar 2020 19:52:00 +0000</pubDate>
				<category><![CDATA[Policy Archives]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://hvvprod.wpengine.com/?p=10379</guid>

					<description><![CDATA[<p>On March 3, Sen. Dick Durbin (D-Ill.), the Senate Minority Whip, expressed his intent in a Senate floor speech to introduce legislation titled the Commission on America’s Medical Security Act. The legislation would assess the dependence of the United States, including public and private payers and federal agencies, on medical products sourced from foreign countries, [&#8230;]</p>
<p>The post <a href="https://www.heartvalvevoice-us.org/durbin-issues-bill-to-safeguard-foreign-manufactured-medical-technology/">Durbin Issues Bill to Safeguard Foreign-Manufactured Medical Technology</a> appeared first on <a href="https://www.heartvalvevoice-us.org">Heart Valve Voice US</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
